Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
FLUPENTIXOL DIHYDROCHLORIDE
Lundbeck Limited
1 Milligram
Coated Tablets
1982-12-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Fluanxol 1 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 1 mg flupentixol present as flupentixol dihydrochloride. Excipients: Also includes lactose monohydrate 37 mg per tablet, and sucrose not more than 66 mg per tablet. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Coated Tablet (Tablet). Round, biconvex, ochre-yellow, sugar-coated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Short-term management of mild to moderate depression with or without anxiety. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults_ Initially 1 mg daily as a single morning dose or 0.5 mg twice daily. After one week the dosage may be increased to 2 mg daily if there is an inadequate clinical response. Daily dosage of more than 2 mg should be divided doses up to a maximum of 3 mg. _Elderly patients_ Elderly patients should receive half the recommended dosages, i.e. 0.5 – 1.5 mg daily. Patients often respond to flupentixol within two or three days. If no effect has been observed within one week of maximum dosage the drug should be withdrawn. _Children:_ Fluanxol is not recommended for use in children due to lack of clinical experience. Reduced renal function Flupentixol can be given in usual doses in patients with reduced renal function. Reduced hepatic function Dose reduction (relative to the degree of hepatic impairment) should be considered. If possible, where assay facilities exist dosage should be adjusted according to serum levels. _Method of administration_ The tablets are swallowed with water. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 19/11/2010_ _CRN 2091831_ _page numb Read the complete document